Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

ZNF765 overexpression

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

ZNF765 overexpression	Hepatocellular Cancer	ZNF765 overexpression	Hepatocellular Cancer	REC-2282 Sensitive: D – Preclinical REC-2282 Sensitive : D	REC-2282 Sensitive: D – Preclinical REC-2282 Sensitive : D
ZNF765 overexpression	Hepatocellular Cancer	ZNF765 overexpression	Hepatocellular Cancer	bleomycin Resistant: D – Preclinical bleomycin Resistant : D	bleomycin Resistant: D – Preclinical bleomycin Resistant : D
ZNF765 overexpression	Hepatocellular Cancer	ZNF765 overexpression	Hepatocellular Cancer	Sensitive: D – Preclinical Sensitive : D	Sensitive: D – Preclinical Sensitive : D
ZNF765 overexpression	Hepatocellular Cancer	ZNF765 overexpression	Hepatocellular Cancer	BMS-722782 Resistant: D – Preclinical BMS-722782 Resistant : D	BMS-722782 Resistant: D – Preclinical BMS-722782 Resistant : D
ZNF765 overexpression	Hepatocellular Cancer	ZNF765 overexpression	Hepatocellular Cancer	NG25 Sensitive: D – Preclinical NG25 Sensitive : D	NG25 Sensitive: D – Preclinical NG25 Sensitive : D
ZNF765 overexpression	Hepatocellular Cancer	ZNF765 overexpression	Hepatocellular Cancer	docetaxel Resistant: D – Preclinical docetaxel Resistant : D	docetaxel Resistant: D – Preclinical docetaxel Resistant : D
ZNF765 overexpression	Hepatocellular Cancer	ZNF765 overexpression	Hepatocellular Cancer	BHG712 Sensitive: D – Preclinical BHG712 Sensitive : D	BHG712 Sensitive: D – Preclinical BHG712 Sensitive : D
ZNF765 overexpression	Hepatocellular Cancer	ZNF765 overexpression	Hepatocellular Cancer	fedratinib Sensitive: D – Preclinical fedratinib Sensitive : D	fedratinib Sensitive: D – Preclinical fedratinib Sensitive : D
ZNF765 overexpression	Hepatocellular Cancer	ZNF765 overexpression	Hepatocellular Cancer	ABT 263 Sensitive: D – Preclinical ABT 263 Sensitive : D	ABT 263 Sensitive: D – Preclinical ABT 263 Sensitive : D
ZNF765 overexpression	Hepatocellular Cancer	ZNF765 overexpression	Hepatocellular Cancer	Sensitive: D – Preclinical Sensitive : D	Sensitive: D – Preclinical Sensitive : D
ZNF765 overexpression	Hepatocellular Cancer	ZNF765 overexpression	Hepatocellular Cancer	PHA 793887 Sensitive: D – Preclinical PHA 793887 Sensitive : D	PHA 793887 Sensitive: D – Preclinical PHA 793887 Sensitive : D
ZNF765 overexpression	Hepatocellular Cancer	ZNF765 overexpression	Hepatocellular Cancer	GSK690693 Sensitive: D – Preclinical GSK690693 Sensitive : D	GSK690693 Sensitive: D – Preclinical GSK690693 Sensitive : D
ZNF765 overexpression	Hepatocellular Cancer	ZNF765 overexpression	Hepatocellular Cancer	OP-11 Sensitive: D – Preclinical OP-11 Sensitive : D	OP-11 Sensitive: D – Preclinical OP-11 Sensitive : D
ZNF765 overexpression	Hepatocellular Cancer	ZNF765 overexpression	Hepatocellular Cancer	GSK525762 Sensitive: D – Preclinical GSK525762 Sensitive : D	GSK525762 Sensitive: D – Preclinical GSK525762 Sensitive : D